pentobarbital will reduce the extent or impact of artemether/lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration with solid CYP3A4 inducers may lead to lowered serum concentrations and lack of antimalarial efficacy
pentobarbital will reduce the extent or outcome of eletriptan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lower the level or impact of alfuzosin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
pentobarbital will decrease the extent or result of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will minimize the level or effect of irinotecan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lessen the level or result of quetiapine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will reduce click here the level or influence of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
Keep an eye on Closely (one)pentobarbital will lower the level or result of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the level or influence of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will reduce the level or effect of siponimod by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of siponimod with a drug that causes moderate CYP2C9 plus a reasonable or sturdy CYP3A4 inducer just isn't advised.
pentobarbital will reduce the level or impact of tamoxifen by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Following stopping a CYP3A4 inducer, because the effects of your inducer decline, the fentanyl plasma concentration will improve which could boost or prolong the two the therapeutic and adverse effects.
With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.
pentobarbital will reduce the level or impact of doxorubicin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.